LK
GILD icon

Lumbard & Kellner’s Gilead Sciences GILD Stock Holding History

Lumbard & Kellner’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Buy
2,636
+676
+34% +$89.1K 0.1% 86
2026
Q1 		$273K Hold
1,960
– – 0.09% 87
2025
Q4 		$241K Hold
1,960
– – 0.08% 94
2025
Q3 		$218K Hold
1,960
– – 0.08% 92
2025
Q2 		$217K Hold
1,960
– – 0.09% 85
2025
Q1 		$220K Buy
+1,960
New +$202K 0.1% 78
2017
Q2 		– Sell
-7,594
Closed -$516K – 88
2017
Q1 		$516K Buy
+7,594
New +$534K 0.31% 50

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lumbard & Kellner's GILD Position: Q2 2026 in Review

Lumbard & Kellner increased its Gilead Sciences (GILD) stake by 34% in Q2 2026, buying an estimated $89.1K and bringing the position to 2,636 shares worth $333K. The position accounts for 0.1% of the portfolio, ranked #86.

Lumbard & Kellner first reported a position in GILD in Q1 2017 and has held it in 7 quarters since. The position peaked at $516K in Q1 2017. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lumbard & Kellner held 2,636 shares of Gilead Sciences worth $333K as of Q2 2026.
  • Lumbard & Kellner bought 676 Gilead Sciences shares in Q2 2026, an estimated $89.1K.
  • Gilead Sciences made up 0.1% of Lumbard & Kellner's portfolio in Q2 2026, its #86 holding.
  • Lumbard & Kellner first reported a position in Gilead Sciences in Q1 2017 and has held it in 7 quarters since.
  • Lumbard & Kellner's Gilead Sciences position peaked at $516K in Q1 2017.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lumbard & Kellner's 13F filing for Q2 2026, filed 6 Aug 2026.